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Abstract 
Cirrhosis is the final outcome of liver fibrosis. Kupffer cell-mediated hepatic inflammation is 
considered to aggravate liver injury and fibrosis. Alternatively-activated macrophages are able 
to control chronic inflammatory events and trigger wound healing processes. Nevertheless, 
the role of alternative Kupffer cell activation in liver harm is largely unclear. Thus, we eval-
uated the participation of alternatively-activated Kupffer cells during liver inflammation and 
fibrosis in the murine model of carbon tetrachloride-induced hepatic damage. To stimulate 
alternative activation in Kupffer cells, 20 Taenia crassiceps (Tc) larvae were inoculated into 
BALBc/AnN female mice. Six weeks post-inoculation, carbon tetrachloride or olive oil were 
orally administered to Tc-inoculated and non-inoculated mice twice per week during other six 
weeks. The initial exposure of animals to T. crassiceps resulted in high serum concentrations of 
IL-4 accompanied by a significant increase in the hepatic mRNA levels of Ym-1, with no al-
teration in iNOS expression. In response to carbon tetrachloride, recruitment of inflam-
matory cell populations into the hepatic parenchyma was 5-fold higher in non-inoculated 
animals than Tc-inoculated mice. In contrast, carbon tetrachloride-induced liver fibrosis was 
significantly less in non-inoculated animals than in the Tc-inoculated group. The latter showed 
elevated IL-4 serum levels and low IFN- concentrations during the whole experiment, as-
sociated with hepatic expression of IL-4, TGF-, desmin and -sma, as well as increased 
mRNA levels of Arg-1, Ym-1, FIZZ-1 and MMR in Kupffer cells. These results suggest that 
alternative Kupffer cell activation is favored in a Th2 microenvironment, whereby such liver 
resident macrophages could exhibit a dichotomic role during chronic hepatic damage, being 
involved in attenuation of the inflammatory response but at the same time exacerbation of 
liver fibrosis. 
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Introduction 
Liver fibrosis is a wound healing process char-
acterized by altered production and accumulation of 
extracellular  matrix  proteins  (ECM)  in  the  hepatic 
parenchyma, such as type I and III collagen, laminin, 
elastin, fibronectin and undulin [1]. In the most ad-
vanced stages, liver fibrosis leads to cirrhosis, portal 
hypertension, liver failure and death [2]. In Western 
countries,  cirrhosis  is  the  seventh  leading  cause  of 
death [3], whereas in Latin America it still represents 
a serious public health problem associated with high 
mortality  rates  (~55/100,000  men  and  14/100,000 
women) [4]. 
Liver fibrosis results from chronic hepatic injury 
[5].  Kupffer  cells,  the  resident  macrophages  of  the 
liver, have been demonstrated to decisively mediate 
wound-related  hepatic  inflammation,  and  conse-
quently initiate liver fibrosis [1, 6, 7]. In response to 
liver damage agents, including harmful use of alco-
hol,  hepatitis  C  virus  infection  (HCV)  and 
non-alcoholic  steatohepatitis,  Kupffer  cells  are  acti-
vated starting to express proinflammatory cytokines 
such  as  tumor  necrosis  factor  alpha  (TNF-),  inter-
leukin (IL) 1 and IL-6, several chemoattractant mol-
ecules as it is the case for monocyte chemotactic pro-
tein 1 (MCP-1) and CXCL8 [8], and some enzymes, 
such as the inducible nitric oxide synthase (iNOS) [9]. 
Consequently, additional immune cells are recruited 
into the  liver that shows  active infiltration of CD4+ 
and  CD8+  T  lymphocytes,  natural  killer  cells,  and 
neutrophils  associated  with  high  levels  of  interfer-
on-gamma (IFN-) and IL-12 [5-10]. As a result of this 
inflammatory scenario, Kupffer cells also synthesize 
profibrogenic  factors,  such  as  transforming  growth 
factor  beta 1  (TGF-1)  capable  of  activating  the  he-
patic stellate cells (HSC), considered to be the most 
important ECM-producing cells in the injured liver [2, 
11].  Thus,  the  participation  of  Kupffer  cells  in  the 
pathogenesis  of  chronic  hepatic  fibrosis  has  been 
mainly related with hepatic inflammation and activa-
tion of HSC [2]. However, a solid body of growing 
evidence  suggests  that  liver  resident  Kupffer  cells 
could  have  additional  roles  during  liver  damage, 
when they display an alternative activation status [12, 
13]. 
Kupffer cells, as the rest of the macrophages, can 
be differentially activated depending on the cytokine 
microenvironment [12, 13]. Kupffer cells exposed to 
Type 1 cytokines, including IL-12 and IFN- exert a 
classical  state  of  activation  associated  with  proin-
flammatory responses through expression of TNF-, 
IL-6,  IL-1,  MCP-1,  and  iNOS  [14,  15].  In  contrast, 
alternatively-activated Kupffer cells have the ability 
to express arginase (Arg), chitinase (Ym) and IL-10 in 
order to promote tissue repair and ameliorate exces-
sive  inflammation  in  response  to  the  Th2-cytokines 
IL-4 and IL-13 [14-16]. Although the actions of classi-
cal  Kupffer  cells  have  been  broadly  described  in 
chronic hepatic diseases [1, 2, 5-11], the role of alter-
natively-activated  Kupffer  cells  during  liver  inflam-
mation and fibrosis remains elusive and controversial 
[12, 13, 16-20]. For instance, recent evidence implicates 
activity of alternative Kupffer cells with restriction of 
fibrosis  [17,  18].  In  this  sense,  Type  1  IL-4  Recep-
tor-deficient mice exhibit an impaired alternative ac-
tivation  in  Kupffer  cells,  which  correlates  with  in-
creased liver inflammation, fibrosis, and death during 
acute  schistosomiasis  by  Schistosoma  mansoni  [18]. 
Similarly, IL-4-activated alternative Kupffer cells im-
prove  both  steatohepatitis  and  fibrosis  during  ex-
perimental and human non-alcoholic fatty liver dis-
ease [12, 13]. On the contrary, other information cor-
relates alternatively-activated Kupffer cells with more 
severe  fibrogenic  response.  To  this  respect,  S. man-
soni-infected IL-21-/- knockout mice show decreased 
hepatic fibrosis clearly associated with low expression 
of IL-4, IL-13, and other markers of alternative Kup-
ffer cell activation, such as Ym-1 and FIZZ-1 (found in 
inflammatory  zone  1,  also  known  as  RELM)  [19]. 
Likewise, liver tissue from IL-5-/- deficient mice dis-
plays less fibrosis in response to S. mansoni eggs when 
Kupffer  cells  exhibit  a  classic  activation  status,  de-
noted  by  diminished  mRNA  levels  of  Arg-1,  Ym-1, 
and  FIZZ-1  [20].  Therefore,  more  experimental  evi-
dence is necessary in order to clarify the function of 
alternative  activation  on  Kupffer  cells  during  liver 
injury and fibrogenesis. 
Helminth parasites are able to stimulate alterna-
tive  activation  in  murine  and  human  macrophages 
[21, 22]. Inoculation of  Taenia crassiceps larvae (ORF 
strain)  into  the  peritoneal  cavity  of  BALB/c  female 
mice is able to bias the host immune response toward 
a Th2-type profile, characterized by activation of the 
STAT6 signaling pathway in immune cells, elevation 
of  IL-4  and  IL-13,  and  a decrease  in  the  IFN-  and 
IL-12  serum  levels  after  six  weeks  post-inoculation 
[23].  As  it  has  been  shown,  this  cytokine  profile  is 
directly involved in alternative activation of murine 
macrophages  that  display  overexpression  of  Arg-1, 
Ym-1, FIZZ-1, and MMR  (macrophage  mannose re-
ceptor) [24-26]. Due to its simplicity and reproduci-Int. J. Biol. Sci. 2011, 7 
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bility, this experimental strategy has become a con-
venient  model  for  studying  the  anti-inflammatory 
properties  of  alternatively-activated  peritoneal  mac-
rophages  during  several  chronic  inflammatory  dis-
eases, such as experimental autoimmune encephalo-
myelitis  and  streptozotocin-induced  type  1  diabetes 
[27,  28].  However,  besides  their  well  described  im-
munosuppressive  characteristics,  alternative  macro-
phages could adopt other functions as wound healer 
cells  with  important  implications  during  the  patho-
genesis  of  hepatic  fibrosis,  as  it  has  also  been  sug-
gested for peritoneal and lung fibrosis [29-32]. 
Thus,  the  main  purpose  of  this  work  was  to 
evaluate the role of alternative Kupffer cell activation 
upon  carbon  tetrachloride-induced  liver  inflamma-
tion and fibrosis in a T. crassiceps-induced Th2 mouse 
model. Our findings may contribute to a better un-
derstanding of the immune mechanisms leading he-
patic  tissue-resident  macrophages  to  mediate  repair 
process during liver damage that could be associated 
with  a  persistent  fibrogenic  response  and  cirrhosis 
progression. 
 
Materials and Methods 
Mice 
Female mice (Mus musculus, strain BALB/cAnN) 
aged between 6-8 weeks were used in all of our ex-
periments. Animals were fed with Purine Diet 5015 
(Purine,  St.  Louis,  MO)  and  water  ad  libitum 
throughout all of the experimental time. All experi-
mental  procedures  were  approved  by  the  Ethical 
Committees of the Hospital General de México and 
the Facultad de Medicina of the Universidad Nacional 
Autónoma  de  México,  according  to  the  University 
Animal Care and Use Committee. 
T. crassiceps inoculation 
A  parasite  stock  of  T.  crassiceps  (ORF-Kuhn2 
strain) [33] larvae was donated to our laboratory by 
Dr. L.I. Terrazas, and preserved by serial intraperito-
neal passage in BALBc/AnN female mice every three 
months. T. crassiceps larvae for each experimental ses-
sion were obtained from one donor female mouse and 
placed  in  tubes  containing  sterile  PBS  1X,  supple-
mented  with  100  U/ml  of  penicil-
lin-streptomycin-fungizone (Gibco, Grand Island). T. 
crassiceps larvae were then centrifuged for 10 min at 
1200 rpm/4°C, discarding the supernatant at the end 
of this interval. This procedure was repeated 3 times 
using  non-supplemented  sterile  PBS  1X.  Finally, 
packed T. crassiceps larvae were placed in fresh sterile 
PBS 1X and twenty viable non-budding T. crassiceps 
larvae of approximately 2 mm in diameter were se-
lected for being separately inoculated into the perito-
neal cavity of different female mice (Tc-inoculated), 
using  a  21GX32  mm  needle  (DL  Medica,  México). 
Non-inoculated control female mice only received 400 
L of sterile PBS 1X. Six weeks post-inoculation, ten 
Tc-inoculated and ten non-inoculated control animals 
were  euthanized  for  determination  of  the  IL-4  and 
IFN- serum levels, as well as evaluation of Ym-1 and 
iNOS expression in liver tissue. 
Experimental groups design and carbon tet-
rachloride administration 
Six  weeks  post-inoculation,  forty  female  mice 
(ten animals per group) were subjected to four dif-
ferent  treatments  as  follows:  a)  animals  previously 
inoculated with 20 T. crassiceps larvae orally received 
carbon tetrachloride (J.T. Baker, Mexico), 2 mg/Kg of 
body  weight,  twice  per  week,  during  six  weeks 
(Tc+CCl4); b) animals previously inoculated with 20 T. 
crassiceps  larvae  received  olive  oil  as  vehicle  orally, 
twice per week, during six weeks (Tc+V); c) animals 
previously treated with 400 L of sterile PBS 1X orally 
received  CCl4,  2  mg/Kg  of  body  weight,  twice  per 
week,  during  six  weeks  (CCl4);  d)  finally,  animals 
previously treated with 400 L of sterile PBS 1X orally 
received olive oil as vehicle twice per week during six 
weeks (V). All experimental groups were euthanized 
six weeks after carbon tetrachloride or vehicle treat-
ment, using a CO2-saturated chamber for blood and 
liver samples collection, as well as for the determina-
tion of the number of larvae. 
Assessment of the liver inflammation and fi-
brosis by histological examination 
Liver  samples  were  collected  from  all  experi-
mental groups, and placed in 4% paraformaldehyde 
(J.T. Baker, Mexico) for 2 weeks. Briefly, tissues were 
washed twice with PBS 1X solution (Sigma-Aldrich, 
USA). They were then dehydrated using 70%, 80%, 
95%, and 100% ethanol (J.T. Baker, Mexico), in sepa-
rate  incubations  of  15  minutes  each.  Subsequently, 
tissues were placed into xylene (J.T. Baker, Mexico) 
for 30 min and, after an extra wash with PBS 1X, em-
bedded in 60°C liquid paraffin during 30 min. After 
this time, liquid paraffin was replaced with new fresh 
60°C paraffin. Once the blocks were solidified after 24 
h  at  room  temperature,  the  liver  tissue  was 
cross-sectioned  in  4  M  slices  using  a  microtome 
(Microtome Olympus Cut 4060, USA). Liver sections 
were  separately  stained  with  hematoxylin-eosin  or 
Sirius red for evaluation of the inflammatory infiltrate 
and liver fibrosis, respectively. According to the mi-
croscopic  characteristics  of  the  nucleus,  the  inflam-Int. J. Biol. Sci. 2011, 7 
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matory  infiltrate  was  determined  by  an  expert 
pathologist as number of polymorphonuclear leuko-
cytes per one hundred hepatocytes in a single-blind 
test.  Liver  fibrosis  was  quantified  as  percentage  of 
Sirius red area, where yellow scars correspond to type 
I collagen, and green scars correspond to type III col-
lagen. Stage of liver fibrosis was assessed by an expert 
pathologist  in  a  single-blind  test  according  to  the 
Metavir Score, where F0 = no fibrosis; F1 = portal fi-
brosis  without  septa;  F2  =  portal  fibrosis  with  few 
septa;  F3  =  numerous  septa  without  cirrhosis;  F4  = 
cirrhosis. Microphotographs were acquired at 20, 40, 
and  100x  magnification,  using  a  Nikon  Micro-
phot-FXA  microscope  coupled  to  a  Nikon  Digital 
Camera DXM1200F. Digital images from hematoxy-
lin-eosin  and  Sirius  red  staining  were  analyzed  by 
means of the MATLAB 7.1 software. 
Serum levels of IL-4 and IFN-γ by ELISA 
Blood  samples  from  all  experimental  groups 
were collected at room temperature, and centrifuged 
at 1200 rpm/30 min. Sera were separated and stored 
at -70°C until use. Briefly, after blocking during 1 h 
with  10%  FCS  in  PBS  1X  pH  7.0,  each  well  was 
washed 3 times, and standard solutions, as well as 50 
μL of each serum sample, were separately added to a 
96-well  microplate  (Costar),  previously  coated  with 
specific IL-4 and IFN- capture antibodies (Peprotech, 
Mexico) during 2 h at 37°C. Biotin-labeled secondary 
antibodies were then added to each well during 1 h at 
37°C. Each well was washed 5 times and Streptavi-
din-AKP (PharMingen, USA), as conjugate solution, 
was added during 30 min at 37°C. After this time, a 
final wash was performed 6 times, and p-Nitrophenyl 
Phosphate (BioLabs, Inc.) in Glycine buffer was added 
and incubated during 30 min at 37°C. Concentration 
of  both  studied  cytokines  was  determined  by  ab-
sorbance at 405 nm using an automatic ELISA reader 
(Thermo Electron Microplate Reader, Mecury Scien-
tific & Chemicals). Final concentration of each meas-
ured cytokine was determined in duplicate, and ex-
pressed as mean ± standard deviation. 
Isolation of liver resident Kupffer cells 
Liver resident Kupffer cells were separately iso-
lated by means of the conventional counterflow cen-
trifugal elutriation method. Briefly, 1 g of each liver 
sample  was  perfused  with  abundant  calcium-free 
Hanks’ balanced salt solution (Invitrogen, USA), and 
gently dispersed on a sterile nylon mesh. Liver sus-
pensions  from  each  experimental  group  were  then 
pooled and placed into a 0.5 mg/mL collagenase A 
solution  (Boehrringer-Mannheim,  Mannheim,  Ger-
many) in RPMI 1640 medium (Gibco BRL, USA) sup-
plemented with 5% fetal calf serum at 35°C for 15 min. 
After this time, liver cell suspensions were separately 
filtered in a sterile nylon mesh and placed into fresh 
calcium-free  Hanks’  balanced  salt  solution  (Invitro-
gen, USA) for subsequent centrifugation at 250 rpm 
during 15 min. Once the supernant was discarded, the 
cell  pellet  was  resuspended  in  10  mL  calcium-free 
Hanks’ balanced salt solution with 15 mL NycoPrepTM 
1.068 (Gibco BRL, USA). The red blood cell fraction 
was  sedimented  at  1000  rpm  for  10  min,  and  cells 
from  the  interphase  were  placed  in  20  mL  calci-
um-free  Hanks’  balanced  salt  solution  to  be  subse-
quently centrifuged at 2000 rpm during 15 min. The 
cell  pellet  was  resuspended  in  5  mL  calcium-free 
Hanks’  balanced  salt  solution,  and  separated  into 
several cell fractions by counterflow centrifugal elu-
triation  using  the  Beckman  JE-5.0  elutriator  rotor, 
coupled  to  a  Sanderson  chamber  (Beckman  Instru-
ments, CA, USA) at 12 mL/min flow rate, using cal-
cium-free Hanks’ balanced salt solution with elutria-
tor speed at 3200 rpm. The intermediate cell fraction 
was used for recovering around 2 X 106 Kupffer cells 
from each pooled experimental group. Purity of Kup-
ffer cell population (~90%) was determined by con-
ventional non-specific esterase and Diff Quick stain 
using a Nikon Microphot microscope at 100x magni-
fication. 
 
Total RNA extraction by Guanidinium thio-
cyanate-phenol-chloroform method 
Liver or isolated Kupffer cell samples from  all 
experimental  groups  were  placed  in  Trizol  reagent 
(Invitrogen, Carlsbad, California), and stored at -70°C 
until use. Briefly, the hepatic tissue was disrupted in 
Trizol  reagent  (1  mL/0.1  g  tissue)  at  4°C.  1  X  106 
Kupffer cells were vortexed for 10 min at 4°C. Sub-
sequently, 0.2 mL of cold chloroform per mL of Trizol 
were added to each sample. After 10 min of incuba-
tion  at  4°C,  and  15  min  of  centrifugation  at  13000 
rpm/4°C, the aqueous phase from each sample was 
recovered and separately placed into 1.6 mL Eppen-
dorf  tubes.  Total  RNA  was  then  precipitated  with 
isopropyl alcohol overnight at 4°C. After this, RNA 
samples were centrifuged at 13000 rpm/4°C during 
15  min,  and  supernatant  was  discarded.  Next,  the 
RNA pellet was washed twice with 100% pure etha-
nol,and dissolved in RNAse-free water treated with 
DEPC (Sigma-Aldrich, USA). RNA concentration was 
determined by absorbance at 260/280 nm, and purity 
was  verified  by  electrophoresis  on  1.0%  denaturing 
agarose gel (Promega, Uniparts, México) in the pres-
ence of 2.2 M formaldehyde. Int. J. Biol. Sci. 2011, 7 
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mRNA expression levels of IFN-γ, IL-12, IL-4, 
IL-13, TNF-α, IL-10, TGF-β1, desmin, α-sma, 
Arg-1, Ym-1, FIZZ-1, MMR, and iNOS by 
RT-PCR 
Total RNA samples from hepatic tissue or iso-
lated Kupffer cells were reverse-transcribed by using 
the M-MLV Retrotranscriptase system and dT primer 
(Invitrogen, USA). cDNA was specifically amplified 
by semi-quantitative PCR using TaqDNA polymerase 
(Biotecnologías Universitarias, UNAM, México), and 
mouse-specific primers to detect the mRNA levels of 
Th1-type cytokines (IFN-, IL-12), Th2-type cytokines 
(IL-4,  IL-13),  proinflammatory  cytokines  (TNF-), 
anti-inflammatory  cytokines  (TGF-1,  IL-10),  molec-
ular  markers  for  activated  HSC  (desmin),  profibro-
genic response-associated markers (-smooth muscle 
actin  [-sma]),  classic  activation  markers  in  macro-
phages (iNOS), and alternative activation markers in 
macrophages (Arg-1, Ym-1, FIZZ-1, MMR) (Table 1). 
18S-ribosomal  RNA  was  used  as  a  control  gene  of 
constitutive expression. Briefly, the 25 µL PCR reac-
tion included 2 µL of previously synthesized cDNA, 5 
µL  of  10X  PCR-buffer  (Perkin-Elmer,  USA),  1  mM 
MgCl, 0.2 mM of each dNTP, 0.05 µM of each specific 
primer,  0.5  L  of  TaqDNA  polymerase  (Bio-
tecnologías Universitarias, México), and DNAse-free 
water. After an initial denaturation step at 94ºC for 5 
min, temperature cycling was as follows: 95°C for 30 
seconds, from 55°C to 62°C (depending on the primer 
sequence)  for  30  seconds,  and  72°C  for  45  seconds 
during 30 or 35 cycles (depending on the primer se-
quence).  An  extra  extension  step  was  completed  at 
72°C/10 min for each amplification session. The 25 µL 
of the PCR reaction were separated by electrophoresis 
on 2% agarose gel (Promega, Uniparts, Mexico), and 
corresponding  bands  were  visualized  through  stain 
with ethidium bromide in the presence of a 100 bp 
ladder as molecular weight marker (Fermentas, Mex-
ico). Relative expression of each amplified gene was 
obtained by optical density analysis (OD) using the 
18S-ribosomal  RNA  as  control  gene  of  constitutive 
expression. 
Experimental design and statistical analysis 
Our results were obtained from two independ-
ent experiments. A sufficient number of BALBc/AnN 
female  mice  were  disposed  into  different  experi-
mental  groups,  consisting  in  10  animals  each.  De-
pendent variables were liver fibrosis degree, number 
of  polymorphonuclear  leukocytes  per  one  hundred 
hepatocytes,  cytokine  concentrations,  and  mRNA 
expression levels of IFN-, IL-12, IL-4, IL-13, TNF-, 
TGF-1,  IL-10,  desmin,  -sma,  iNOS,  Arg-1,  Ym-1, 
FIZZ-1,  and  MMR.  Independent  variables  were 
presence or absence of inoculation with T. crassiceps 
larvae,  as  well  as  carbon  tetrachloride  and  vehicle 
treatment.  Data  are  presented  as  mean  ±  standard 
deviation, and analyzed by means of the Shapiro-Wilk 
test for determination of normality. Depending on the 
number  of  compared  groups,  data  were  analyzed 
using t-student, or one-way ANOVA, followed by the 
post-hoc  Tukey  test,  using  the  GraphPad  Prism  5 
software.  Differences  were  considered  significant 
when P<0.05. 
 
Table 1. Primer sequences for PCR amplification. 
Gene  Forward Primer  Reverse Primer  Product Length 
IL-4  5’-CGAAGAACACCACAGAGAGTGAGCT-3’  5’-GACTCATTCATGGTGCAGCTTATCG-3’  181 
IFN-  5’-AGCGGCTGACTGAACTCAGATTGTAG-3’  5’-GTCACAGTTTTCAGCTGTATAGGG-3’  247 
IL-12p40  5’-ACATCAGACCAGGCAGCTCGCAG-3’  5’-GAGTGGCTCAGAGTCTCGCCTCC-3’  331 
IL-10  5’-ACCTGGTAGAAGTGATGCCCCAGGCA-3’  5’-CTATGCAGTTGATGAAGATGTCAAA-3’  237 
TGF-1  5’-TACCCGGCGTTCCTCAGACG-3’  5’-CAGGAGTCGCGGTGAGGCTCTG-3’  309 
TNF-  5’-TGGTGCCAGCCGATGGGTTG-3’  5’-CTGCCCGGACTCCGCAAAGT-3’  299 
Desmin  5’-GCCCTGGCTATTGGCAGGTGT-3’  5’-CCATGAGGGCAGTTTTCAGGCC-3’  233 
-sma  5’-AGCGGGCATCCACGAAACCA-3’  5’-AGCCAAGATGGAGCCACCGA-3’  229 
Arg-1  5’-CAGAAGAATGGAAGAGTCAG-3’  5’-CAGATATGCAGGGAGTCACC-3’  250 
Ym-1  5’-TCACAGGTCTGGCAATTCTTCTG-3’  5’-TTTGTCCTTAGGAGGGCTTCCTC-3’  436 
FIZZ-1  5’-GGTCCCAGTGCATATGGATGAGACCATAG-3’  5’-CACCTCTTCACTCGAGGGACAGTTGGCAGC-3’  290 
MMR  5’-GAATAGAGCCAAGGGCGTGGTCG-3’  5’-CTGCAGGTCAGCAGGTTTAGGC-3’  391 
iNOS  5’-CTGGAGGAGCTCCTGCCTCATG-3’  5’-GCAGCATCCCCTCTGATGGTG-3’  449 
18S  5’-CGCGGTTCTATTTTGTTGGT-3’  5’-AGTCGGCATCGTTTATGGTC-3’  219 
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Results 
Initially, Tc-inoculated and non-inoculated mice 
were euthanized after six weeks post-inoculation with 
20 T. crassiceps larvae or 400 L of sterile PBS 1X, re-
spectively.  The  exposure  to  T.  crassiceps  induced  a 
significant  10-fold  increase  in  the  IL-4  serum  levels 
from  Tc-inoculated  animals,  when  compared  with 
non-inoculated control mice (Fig. 1A). In contrast, the 
IFN- levels showed a 4-fold decrease at the same time 
(Fig.  1B).  Furthermore,  the  hepatic  tissue  from 
Tc-inoculated animals displayed a significant 14-fold 
increase  in  Ym-1  expression  (Fig.  1C),  while  the 
mRNA levels of iNOS exhibited no variation between 
both  experimental  groups  (Fig.  1D).  It  is  thus  clear 
that the immune profile from Tc-inoculated mice was 
polarized toward a Th2-type, which could be associ-
ated with the alternative activation microenvironment 
observed in these animals. At this time, carbon tetra-
chloride  or  vehicle  started  to  be  administered  to  a 
sufficient number of Tc-inoculated animals (Tc+CCl4 
and  Tc+V  groups,  respectively)  during  six  weeks. 
Parallel, non-inoculated control mice were subjected 
to this same experimental scheme (CCl4 and V groups, 
respectively). 
 
 
 
Figure 1. T. crassiceps-inoculation induces elevation of IL-4 and hepatic expression of Ym-1. Six weeks post-inoculation, IL-4 
(A) and IFN- (B) serum levels were determined from Tc-inoculated and non-inoculated mice by ELISA. Ym-1 (C) and iNOS 
(D) expression was directly measured from the hepatic tissue of both animal groups by RT-PCR. Tc-inoculated = mice 
inoculated with T. crassiceps; Control = non-inoculated mice treated with 400 L of sterile PBS 1X. Results from C and D are 
presented as optical densitometry (OD) using 18S as control gene of constitutive expression. Data were obtained from 2 
independent experiments (10 animals per group), and expressed as mean ± standard deviation. Data were considered 
significant when P<0.05. 
 Int. J. Biol. Sci. 2011, 7 
 
 
http://www.biolsci.org 
1279 
 After six weeks of carbon tetrachloride or vehi-
cle treatment, the number of larvae located at the per-
itoneal cavity of Tc+CCl4 and Tc+V subjects revealed 
no significant differences (412±81 and 378±65, respec-
tively). It is important to say that the presence of T. 
crassiceps  was  not  related  to  hepatic  damage,  since 
neither inflammation nor fibrosis was observed in the 
liver of Tc+V animals (Figs. 2A and 3B). However, the 
CCl4 mice group showed an increase in the inflam-
matory cell recruitment into the liver (~50 polymor-
phonuclear leukocytes per 100 hepatocytes, predom-
inantly  neutrophils)  when  compared  with  V  and 
Tc+V healthy groups (Fig. 2B). In contrast, when car-
bon tetrachloride was administered to Tc-inoculated 
subjects,  a  scarce  infiltration  of  polymorphonuclear 
leukocytes was denoted at the hepatic parenchyma of 
these animals (Fig. 2B). 
 
 
Figure 2. T. crassiceps-inoculation prevents recruitment of inflammatory cells into the liver in response to carbon tetra-
chloride. Tc-inoculated and non-inoculated mice orally received carbon tetrachloride or olive oil twice per week during six 
weeks. (A) Liver sections from all experimental groups were stained with hematoxylin-eosin. (B) The inflammatory infiltrate 
was quantified as number of polymorphonuclear leukocytes per one hundred hepatocytes in a single-blind test. V = 
non-inoculated mice receiving olive oil as vehicle; CCl4 = non-inoculated mice receiving carbon tetrachloride; Tc+V = mice 
previously inoculated with T. crassiceps receiving olive oil; Tc+ CCl4 = mice previously inoculated with T. crassiceps receiving 
carbon tetrachloride. Scale bar = 20 M. Data were obtained from 2 independent experiments (10 animals per group), and 
expressed as mean ± standard deviation. ***P<0.0001. 
 
Unexpectedly, the Sirius red stain revealed that 
Tc+CCl4 mice displayed a more active profibrogenic 
response in relation with V, Tc+V and CCl4 animal 
groups (Fig. 3A and B). The percentage of type I col-
lagen from Tc+CCl4 liver sections was around 8.5%, 
while type III collagen represented 4% from each an-
alyzed sample (Fig. 3C). On the contrary, CCl4 mice 
showed approximately 3.7% and 0.34% of type I and Int. J. Biol. Sci. 2011, 7 
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III collagen, respectively (Fig. 3C). According to the 
Metavir Score, 65% of the Tc+CCl4 experimental sub-
jects  exhibited  a  severe  stage  of  liver  fibrosis  (F3), 
whilst 35% showed an intermediate degree (F2), after 
six weeks of carbon tetrachloride administration (Ta-
ble 2). At the same time, most of the CCl4 group (83%) 
presented a consistent mild stage of liver fibrosis (F1), 
and only around 16.7% developed a moderate degree 
(F2) of ECM accumulation at the hepatic parenchyma 
(Table 2). Although liver collagen content was signif-
icantly higher in CCl4 animals than in V and Tc+V 
healthy controls (F0), it was noticeably 3-fold less in 
relation  to  that  observed  in  the  hepatic  tissue  from 
Tc+CCl4 mice (Fig. 3C). 
 
 
Figure  3.  T.  crassiceps-inoculation  aggravates  liver  fibrosis  in  response  to  carbon  tetrachloride.  Tc-inoculated  and 
non-inoculated mice orally received carbon tetrachloride or olive oil twice per week during six weeks. (A) Liver sections 
from all experimental groups were stained with Sirius red for fibrosis assessment. (B) Sirius red staining under polarized light 
for determination of type I (yellow scars) and III (green scars) collagen. (C) Content of hepatic collagen from all experimental 
groups was quantified as percent of Sirius red area using the MATLAB 7.1 software  in a single-blind test. V = 
non-inoculated mice receiving olive oil as vehicle; CCl4 = non-inoculated mice receiving carbon tetrachloride; Tc+V = mice 
previously inoculated with T. crassiceps receiving olive oil; Tc+ CCl4 = mice previously inoculated with T. crassiceps receiving 
carbon tetrachloride. Scale bar = 20 M. Data were obtained from 2 independent experiments (10 animals per group), and 
expressed as mean ± standard deviation. **P<0.001. ***P<0.0001. Int. J. Biol. Sci. 2011, 7 
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Table 2. Liver fibrosis degree from all experimental groups according to the Metavir Score. Data are presented as per-
centage. 
  Treatment 
Liver fibrosis degree  V  CCl4  Tc+V  Tc+CCl4 
F0  100 (20/20)  0  100 (20/20)  0 
F1  0  83.3 (15/18)  0  0 
F2  0  16.6 (3/18)  0  35.3 (6/17) 
F3  0  0  0  64.7 (11/17) 
F4  0  0  0  0 
 
 
In  order  to  confirm  that  neither  carbon  tetra-
chloride administration nor the whole duration of the 
experiment modified the levels of Th1 and Th2-type 
cytokines,  serum  concentrations  of  IL-4  and  IFN- 
were measured again from each experimental group 
of mice (Fig. 4). The levels of IL-4 remained signifi-
cantly increased in both Tc+V and Tc+CCl4 animals, 
when compared to their corresponding V and CCl4 
rodent groups (Fig. 4A). In contrast, the IFN- con-
centration was considerably augmented in the CCl4 
group,  while  Tc+V  and  Tc+CCl4  mice  exhibited  re-
duced levels of this Th1-type cytokine at the end of 
the experiment (Fig. 4B). 
Such  Th2-biased  cytokine  profile  favored  the 
establishment of an alternative activation microenvi-
ronment at the liver of Tc+V and Tc+CCl4 subjects. In 
fact,  the  hepatic  expression  of  IL-4  was  clearly  in-
duced by the presence of T. crassiceps (Fig. 4C), with 
no  alteration  in  the  expression  levels  of  IFN-(Fig. 
4D). On the contrary, the IL-12 expression was evi-
dently associated with exposure to carbon tetrachlo-
ride, as CCl4 and Tc+CCl4 mice exhibited a 3-fold in-
crease when compared to V and Tc+V rodent groups 
(Fig. 4E). The expression of IL-10 did not exhibit any 
significant  modification  throughout  all  studied  ani-
mal groups (Fig. 4F). In a similar way, expression of 
TNF- was not modified by the carbon tetrachloride 
administration, nor was it due to inoculation with T. 
crassiceps (Fig. 4H), suggesting that ECM overproduc-
tion in response to liver damage may not be exclu-
sively  related  with  an  inflammato-
ry/anti-inflammatory  balance,  but  also  with  devel-
opment  of  a  wound  healing  process  favored  in  an 
alternative  activation  microenvironment.  Moreover, 
liver  expression  of  TGF-1  (a  Th2-related  cytokine 
able to suppress the immune response and stimulate 
HSC activation) was discreetly increased in Tc+V and 
Tc+CCl4  mice,  suggesting  a  role  for  HSC  (Fig.  4G). 
Nonetheless,  mRNA  levels  of  desmin  (a  typical 
marker  for  activated-HSC)  were  not  significantly 
modified  in  these  same  animal  groups  (Fig.  4I), 
whereas  -sma  expression  (profibrogenic  re-
sponse-associated  marker)  displayed  a  clear  2-fold 
increase (Fig. 4J), which indicates a possible role for 
alternatively-activated Kupffer cells as wound healing 
promoters during the pathogenesis of liver fibrosis. 
A strong alternative activation was observed in 
Kupffer cells isolated from Tc+V and Tc+CCl4 liver 
samples, as it can be seen in figure 5. In this sense, 
expression  of  Arg-1  was  significantly  induced  by 
2.5-fold  in  response  to  T. crassiceps  (Fig.  5A).  Also, 
Kupffer cells from Tc+V and Tc+CCl4 animals showed 
a marked increase in the mRNA levels of Ym-1 and 
FIZZ-1 by 11 and 5-fold, respectively (Fig. 5B and C). 
In addition, expression of MMR in these liver resident 
macrophages  was  2-fold  augmented  in  both 
Tc-inoculated  groups,  when  compared  with  V  and 
CCl4 subjects (Fig. 5D). Although the mRNA levels of 
iNOS  had  no  significant  differences  throughout  all 
studied groups, there was a clear 2.5-fold decrease in 
the  expression  of  this  classic  activation  marker  in 
Tc+CCl4 animals when compared to CCl4 mice (Fig. 
5E). 
Discussion 
In  this  work  we  describe  that  alternative-
ly-activated Kupffer cells could be directly associated 
with  liver  fibrosis  exacerbation,  without  necessarily 
inducing an active inflammatory response in this or-
gan. Previous works have demonstrated that alterna-
tive activation of peripheral and tissue-resident mac-
rophages is dependent on Th2-type cytokines, such as 
IL-4 and IL-13 [12, 13, 18]. In order to guarantee an 
accurate alternative Kupffer cell activation through-
out the whole duration of our experiments, we used 
the Taenia crassiceps murine model, which due to its 
simplicity  and  reproducibility  has  been  widely  uti-
lized for polarizing the immune cytokine pattern from 
the  Th1-type  toward  a  Th2-related  profile  in  short 
periods of time [34-36].  
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Figure 4. Th2-biased cytokine profile induces a hepatic microenvironment consistent with alternative macrophage acti-
vation. Six weeks after carbon tetrachloride or olive oil treatment, IL-4 (A) and IFN- (B) serum levels were determined 
from all experimental groups by ELISA. mRNA levels of IL-4, IFN-, IL-12, IL-10, TGF-1, TNF-, desmin, and -sma were 
directly evaluated from the hepatic tissue of all studied groups by RT-PCR. All results from C to J are presented as optical 
densitometry (OD) using 18S as control gene of constitutive expression. V = non-inoculated mice receiving olive oil as 
vehicle; CCl4 = non-inoculated mice receiving carbon tetrachloride; Tc+V = mice previously inoculated with T. crassiceps 
receiving olive oil; Tc+ CCl4 = mice previously inoculated with T. crassiceps receiving carbon tetrachloride. Data were 
obtained from 2 independent experiments (10 animals per group), and expressed as mean ± standard deviation. *P<0.05. 
**P<0.001. ***P<0.0001. Int. J. Biol. Sci. 2011, 7 
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Figure 5. T. crassiceps-associated Th2 microenvironment induces alternative activation of hepatic Kupffer cells. Six weeks 
after carbon tetrachloride or olive oil treatment, Kupffer cells were isolated from the hepatic tissue of all experimental 
groups by the conventional counterflow centrifugal elutriation method. The mRNA levels of Arg-1, Ym-1, FIZZ-1, MMR, and 
iNOS were evaluated in those isolated Kupffer cells by RT-PCR. Results from A to E are presented as optical densitometry 
(OD) using 18S as control gene of constitutive expression. V = non-inoculated mice receiving olive oil as vehicle; CCl4 = 
non-inoculated mice receiving carbon tetrachloride; Tc+V = mice previously inoculated with T. crassiceps receiving olive oil; 
Tc+ CCl4 = mice previously inoculated with T. crassiceps receiving carbon tetrachloride. Data were obtained from 2 in-
dependent  experiments  (5  animals  per  group),  and  expressed  as  mean  ±  standard  deviation.  *P<0.05.  **P<0.001. 
***P<0.0001. Int. J. Biol. Sci. 2011, 7 
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In fact, an extensive body of experimental evi-
dence  indicates  that  T.  crassiceps-inoculated  female 
mice are able to display a strong Th2-biased cytokine 
profile, characterized by elevation of IL-4 and IL-13 
serum levels with concomitant reduction in IFN- in 
less than 6 weeks [22, 34-36]. In consequence, most of 
the  peritoneal  macrophage  population  is  activated 
under  a  suppressive  alternative  phenotype,  as  has 
been  extensively  described  [34,  37,  38].  Our  results 
suggest that high levels of IL-4 are not only related 
with alternative activation on peritoneal macrophag-
es, but also upon tissue-resident macrophages, as it is 
the case for hepatic Kupffer cells. In our experimental 
model,  Kupffer  cells  from  T.  crassiceps-inoculated 
animals expressed a typical repertoire of alternative 
activation-linked  markers,  including  Arg-1,  Ym-1, 
FIZZ-1, and MMR, without increasing the iNOS ex-
pression. Hence, we assume that these liver-resident 
macrophages showed an alternative activation state at 
the time in which carbon tetrachloride started to be 
administered, and throughout the whole time of our 
observations. 
As  expected,  in  absence  of  liver  dam-
age-stimulus neither inflammation nor fibrosis were 
detected in the hepatic tissue of V subjects, even those 
exposed  to  T. crassiceps  (Tc+V).  On  the  other  hand, 
after  six  weeks  of  carbon  tetrachloride  treatment,  a 
progressive inflammatory infiltrate accompanied with 
moderate  fibrosis  (F1-F2,  P<0.001)  was  observed  in 
the liver of CCl4 mice, which is consistent with the 
classic concept that fibrosis is often related to hepatic 
damage and inflammation [5-13, 39-41]. Interestingly, 
our findings suggest an improvement of the local in-
flammation, but a simultaneous aggravation of liver 
fibrosis,  when  a  polarized  Th2  cytokine  microenvi-
ronment is present, as it is the case for Tc+CCl4 ani-
mals.  These  apparently  controversial  results  can  be 
explained from the fact that Th2 cytokines are able to 
induce alternative activation on macrophages which 
exhibit  a  high  capacity  of  mediating  both  immuno-
suppressive and wound healing actions [32-37]. Our 
results  indicate  a  systemic  and  local  Th2-immune 
profile, denoted by high levels of circulating IL-4, low 
concentrations  of  IFN-,  and  hepatic  expression  of 
IL-4  and  TGF-1.  In  consequence,  most  of  the  liv-
er-resident Kupffer cells showed an alternative phe-
notype consistent in overexpression of Arg-1, Ym-1, 
FIZZ-1,  and  MMR.  Interestingly,  FIZZ-1  and  Ym-1 
have  been  implicated  in  tissue  remodeling  and  at-
tenuation of the inflammatory response, respectively 
[42-43].  Additionally,  Arg-1  is  strongly  associated 
with nitric oxide (NO) suppression and promotion of 
collagen  synthesis  for  conversion  of  L-arginine  into 
L-ornithine,  and  subsequently  into  proline  [29,  32]. 
Although  the  role  of  alternatively-activated  macro-
phages in immunomodulation and fibrogenesis is still 
controversial  [16-20,  42-44],  we  speculate  that 
Th2-related alternative Kupffer cells are able to exert a 
dual role during chronic liver injury, characterized by 
prevention of the inflammatory cell recruitment into 
the hepatic parenchyma but, at the same time, exac-
erbation of liver fibrosis. To our knowledge, this work 
is one of the first studies reporting experimental evi-
dence suggesting that liver fibrosis is not necessarily a 
consequence of local chronic inflammation, but that it 
could also be an independent cellular process by itself, 
in  charge  of  mediating  injured  tissue  repair  in  re-
sponse to liver damage agents. 
An intriguing question involves the participation 
of  HSC  during  alternative  Kupffer  cell  activa-
tion-prompted liver fibrosis. HSC have been proposed 
as the main collagen-producing cells during chronic 
hepatic  injury  [1,  2].  Once  activated  in  response  to 
hepatocyte necrosis, free radicals such as NO, as well 
as PDGF (platelet-derived growth factor), TNF- and 
TGF-1, these HSC transdifferentiate into myofibro-
blast-like cells starting to overproduce ECM [1]. In our 
experiments,  the  mild  stage  of  hepatic  fibrosis  ob-
served  in  T.  crassiceps  non-inoculated  mice  may  be 
related to TGF-1 expression, and then activation of 
HSC. On the other hand, although Tc+CCl4 animals 
exhibited a significant increase in TGF-1 and -sma, 
no differences were detected at the hepatic expression 
of desmin, which has been typically associated with 
HSC activation [45]. Thus, our data agree with pre-
vious information demonstrating that HSC promote 
liver fibrosis in response to carbon tetrachloride and 
Th1-related  proinflammatory  stimulus  [5,  45-47]. 
However,  during  sustained  Th2-type  profiles,  alter-
natively-activated  Kupffer  cells  may  be  important 
contributors in collagen synthesis, probably leading to 
an active fibrogenic state. In light of these results, the 
common  concept  that  Th2  responses  correlate  with 
severe  liver  fibrogenesis  [2,  48]  could  be  explained, 
since 1) Kupffer cells are alternatively stimulated in 
presence of Th2-cytokines, and, 2) once activated, they 
show  great  ability  to  elicit  local  wound  healing,  as 
other  authors  have  recently  suggested  during  both 
human neuromuscular sarcoidosis, and experimental 
murine lung fibrosis [49, 50]. 
As mentioned, hepatic fibrosis leads to cirrhosis 
as a consequence of chronic liver diseases [1, 51, 52]. 
Furthermore,  intestinal  helminths  are  still  a  public 
health problem in developing economies [53-55]. Due 
to the fact that both chronic liver diseases and hel-
minth  infections  are  prevalent  conditions  in  many 
countries from Latin America, Asia and Africa, their 
coexistence is highly probable. Thus, the evaluation of Int. J. Biol. Sci. 2011, 7 
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whether the presence of helminth parasites correlates 
with severe liver fibrosis in a more real clinical sce-
nario is  worthy of consideration, since these patho-
gens have exerted the ability to switch the host im-
mune  response  from  the  Th1-profile  toward  a 
Th2-type in both mice and humans [56-58]. It is im-
portant  to  clarify  that  Kupffer  cell  phenotype  was 
characterized only by means of mRNA analysis. Since 
posttranscriptional  and  posttranslational  modifica-
tions  can  decisively  influence  the  final  outcome  of 
most  of  the  physiological  and  pathological  process, 
further  research  is  necessary  in  order  to  determine 
such Kupffer cell activation markers and cytokines at 
protein and protein activity levels. Finally, in addition 
to  providing  experimental  evidence  suggesting  that 
alternatively-activated Kupffer cells could be capable 
of exacerbating liver fibrosis without inducing a local 
inflammatory response, our results could contribute 
to a better understanding of the immune mechanisms 
governing classic and alternative activation in these 
liver resident macrophages. Moreover, these findings 
may offer novel therapeutic targets focused  on pre-
venting a prolonged alternative activation in Kupffer 
cells  for  improving  liver  fibrosis  and  cirrhosis  pro-
gression. 
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